Hair loss induced by dopamine agonist: Case report and review of the literature

Parkinsonism and Related Disorders

Volumn 10, Issue 1, 2003, Pages 51-52

  Miwa, Hideto ^a   Kondo, Tomoyoshi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Alopecia; Cabergoline; Dopamine; Hair loss; Parkinson's disease

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

AGED; ARTICLE; CASE REPORT; DISEASE COURSE; DOPAMINERGIC SYSTEM; FEMALE; HAIR LOSS; HUMAN; MEDICAL LITERATURE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0141565327     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(03)00058-0     Document Type: Article

References (8)

1. Marshall A., Williams M.J. Alopecia and levodopa. Br Med J. 2:1971;47.
2. Blum I., Leiba S. Increased hair loss as a side effect of bromocriptine. New Engl J Med. 303:1980;1418.
3. Fabre N., Montastruc J.L., Rascol O. Alopecia: an adversive effect of bromocriptine. Clin Neuropharmacol. 16:1993;266-268.
4. Tabamo R.E., Di Rocco A. Alopecia induced by dopamine agonists. Neurology. 58:2002;829-830.
5. Grauer M.T., Sieb J.P. Alopecia induced by dopamine agonists. Neurology. 59:2002;2012.
6. Factor S.A., Sanchez-Ramos J.R., Weiner W. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. J Neurol Neurosurg Psychiatry. 51:1988;529-533.
7. Paus R., Peters E.M.J., Eichmüller S., Botchkarev V.A. Neural mechanisms of hair growth control. J Invest Dermatol Symp Proc. 2:1997;61-68.
8. Peters E.M.J., Maurer M., Botchkarev V.A., Gordon D.S., Paus R. Hair growth-modulation by adrenergic drugs. Exp Dermatol. 8:1999;274-281.